The single meningococcal vaccine is pentavalent — meaning it protects against five different meningococcal groups: A, B, C, W and Y.
The advisory committee voted 10-4 in favor of recommending the vaccine for use when current options of an MenACWY vaccine and MenB are recommended in the same visit, which is the case “for healthy individuals ages 16–23 years who choose to receive MenB vaccination and individuals 10 years and older who are at increased risk,” according to information published by the American Academy of Pediatrics.
Now that the advisory committee has given its recommendations, CDC Director Mandy Cohen, MD, will review them and decide on their approval.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
